Article Per Year (5 Year)
p-Index From 2020 - 2025
8.367
P-Index
This Author published in this journals
All Journal Biology, Medicine, & Natural Product Chemistry Jurnal Ilmiah Universitas Batanghari Jambi Jurnal Inovasi Farmasi Indonesia Abdimas Galuh : Jurnal Pengabdian Kepada Masyarakat Well Being PHARMACOLOGY, MEDICAL REPORTS, ORTHOPEDIC, AND ILLNESS DETAILS (COMORBID) International Journal of Science and Environment Journal of Engineering Science and Technology Management Business and Economic Publication Jurnal Ilmiah Multidisiplin Indonesia Komunita: Jurnal Pengabdian dan Pemberdayaan Masyarakat Jurnal Media Akademik (JMA) Assoeltan: Indonesian Journal of Community Research and Engagement Contemporary Journal of Applied Sciences (CJAS) Journal of Social Science and Multidisciplinary Analysis Jurnal Intelek Insan Cendikia SEARCH: Science Education Research Gotong Royong Jurnal Pengabdian Kepada Masyarakat Al-Amin Interaksi : Jurnal Pengabdian Kepada Masyarakat Jurnal Informatika dan Kesehatan International Journal of Contemporary Sciences (IJCS) Jurnal Bioteknologi & Biosains Indonesia (JBBI) Khidmah Nusantara J-CEKI Joong-Ki Amaluna: Jurnal Pengabdian Masyarakat Galen: Jurnal Ilmu Farmasi dan Kesehatan Journal Health of Indonesian HelFin Journal International Journal of Science and Society (IJSS) Jurnal Kajian dan Inovasi Ilmu (JKII) Mitra Jurnal Pengabdian Masyarakat Multidisiplin (MJPMM) JES-TM Social and Community Service
Yuneka Saristiana
Prodi Pendidikan Profesi Apoteker, Fakultas Ilmu Kesehatan, Universitas Kadiri
Religion Agriculture, Biological Sciences & Forestry Arts Humanities Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Civil Engineering, Building, Construction & Architecture Computer Science & IT Control & Systems Engineering Decision Sciences, Operations Research & Management Earth & Planetary Sciences Economics, Econometrics & Finance Education Electrical & Electronics Engineering Engineering Environmental Science Health Professions Immunology & microbiology Languange, Linguistic, Communication & Media Law, Crime, Criminology & Criminal Justice Materials Science & Nanotechnology Mathematics Medicine & Pharmacology Neuroscience Nursing Physics Public Health Social Sciences Veterinary Other

Published : 67 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 67 Documents
Search

 1   2   3   4   5 
Analisa Biaya Terapi Antibiotik Ceftriakson pada Pasien Infeksi Demam Tifoid Rawat Inap Rumah Sakit Tahun 2020 Anggi Restyana; Fendy Prasetyawan; Yuneka Saristiana; Nisa Azzahra Dentika; Nina Nur Jannah
Jurnal Ilmiah Universitas Batanghari Jambi Vol 22, No 3 (2022): Oktober
Publisher : Universitas Batanghari Jambi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33087/jiubj.v22i3.2286

Abstract

Typhoid fever is an infection of the digestive tract caused by Salmonella typhi (Eberthella typhosa) results in inflammation of the small intestine and the lumen of the digestive tract. Ceftriaxone antibiotic treatment costs for hospitalized typhoid illness patients in 2020 were the focus of this investigation. A cross-sectional strategy was used in the study design, which was based on the collecting of medical records and funding records. From October 2021 to December 2021, the trial was conducted at Hospital X. A sample of typhoid patients admitted to the inpatient ward of Hospital X, with BPJS payment status, was used for this study's data collection. For typhoid patients at Jombang Regency X Hospital, the average cost of ceftriaxone antibiotics totaled IDR 1,502,796 per patient.
UNIFORMITY OF WEIGHT TESTING OF THE RECIPE MIXTURE FOR THE QUALITY OF PARACETAMOL POWDER FOR PEDIATRIC PATIENTS AT KHODIJAH PHARMACY IN JOMBANG REGENCY IN 2022: Uji Keseragaman Bobot Resep Racikan Terhadap Kualitas Serbuk Bagi (Pulveres) Paracetamol Pada Pasien Anak di Apotek Khodijah Kabupaten Jombang Tahun 2022 Yuneka Saristiana; Fendy Prasetyawan; Charliandri Saputra Wahab; Nanda Ardianto; Lily Aina
Jurnal Inovasi Farmasi Indonesia (JAFI) Vol. 4 No. 2 (2023): Jurnal Inovasi Farmasi Indonesia (JAFI)
Publisher : Universitas Kadiri

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Jenis sediaan farmasi yang sering digunakan untuk anak dan bayi adalah serbuk. Ada dua jenis serbuk oral yaitu terbagi (pulveres) dan tidak terbagi (pulvis). Sediaan pulveres digunakan paling banyak pada pasien anak, mencapai 38% dibandingkan dengan sediaan lain seperti sirup, kapsul, injeksi, dan inhalasi. Ketidakseragaman bobot pada sediaan pulveres dapat terjadi akibat pembagian yang tidak merata, dan ini dapat menyebabkan perubahan dosis. Penelitian digunakan untuk menilai keseragaman bobot resep pulveres mengukur serbuk paracetamol berdasarkan standar farmakope dan persyaratan kualitas yang berlaku. Penelitian ini merupakan ekperimental dengan pendekatan deskriptif dan mengunakan desain Cross sectional dengan menggunakan alat sebagai timbangan analitik milligram. Persyaratan dalam Farmakope Indonesia Edisi III, keseragaman bobot parasetamol dalam resep racikan sediaan serbuk bagi (pulveres) bentuk bungkus (puyer) di apotek Khadijah kabupaten Jombang tidak mencapai standar yang ditetapkan, dengan hanya mencapai 27%.
The Efficacy of Antiviral Medications in Managing Blood Oxygen Levels in Covid-19 Patients Afflicted by Chronic Kidney Conditions Fendy Prasetyawan; Faisal Akhmal Muslikh; Anis Akhwan Dhafin; Elsa Mahardika Putri; Yuneka Saristiana; Susilo Margining Raharjo
Contemporary Journal of Applied Sciences Vol. 1 No. 1 (2023): November 2023
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/cjas.v1i1.7030

Abstract

This research assesses the efficacy and safety of employing antiviral drugs in individuals with COVID-19 and chronic kidney disease. The study results reveal a reduced effectiveness of the drug in enhancing oxygen saturation in patients, as indicated by a p-value of 0.026 for SpO2. Consequently, the administration of antiviral drugs to individuals with chronic kidney disease warrants careful consideration. Moreover, there is a need to pay attention to the safety aspects of antiviral drug utilization, particularly with a p-value of 0.026 for Clcr. It is advisable to refrain from using specific antiviral drugs, such as favipiravir, in COVID-19 patients with chronic kidney conditions. However, contemplating the use of remdesivir at an appropriate dosage may be viable if the patient's glomerular filtration rate (GFR) exceeds 30 ml/minute. The study's conclusion underscores the significance of meticulous and personalized management when employing antiviral drugs in COVID-19 patients with chronic kidney disease. A comprehensive consideration of factors such as effectiveness, safety, and the patient's renal health is imperative to ensure an optimal and tailored treatment approach.
Efficacy of Antiviral Medications in Decreasing Inflammation Levels Among Covid-19 Patients Experiencing Chronic Kidney Disease (CKD) Fendy Prasetyawan; Faisal Akhmal Muslikh; Anis Akhwan Dhafin; Elsa Mahardika Putri; Yuneka Saristiana; Susilo Margining Raharjo
Contemporary Journal of Applied Sciences Vol. 1 No. 1 (2023): November 2023
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/cjas.v1i1.7037

Abstract

Individuals with Chronic Kidney Disease (CKD) face an elevated risk of severe COVID-19 infection. A comprehensive investigation into the effectiveness of antiviral medications in treating COVID-19 patients is imperative. The primary goal is to assess the severity of the illness and the efficacy of antiviral drugs in individuals with COVID-19 and CKD following antiviral treatment at Dr. Soedomo Trenggalek Hospital. This study adopts a cross-sectional approach, employing purposive sampling for sample selection. Retrospective data from 2022 medical records of COVID-19 patients diagnosed with CKD are analyzed. The research findings highlight the efficacy of antiviral drugs in diminishing inflammation levels in COVID-19 patients, as indicated by a significant p-value of 0.000. However, the leukocyte data proved inadequate in determining the reduction in inflammatory levels. Therefore, obtaining data on C-reactive protein (CVR) and lymphocytes is crucial for a more accurate measurement. The p-value for ClCr is 0.842.
Frekuensi Penggunaan Obat Antivirus Pada Pasien SARS-CoV-2 dengan Penyakit Ginjal Kronis di Instalasi Farmasi Rawat Inap Rumah Sakit Fendy Prasetyawan; Yuneka Saristiana; Faisal Akhmal Muslikh; Ratna Mildawati; Chandra Arifin; Abd Rofiq
Jurnal Intelek Insan Cendikia Vol. 1 No. 1 (2024): Maret 2024
Publisher : PT. Intelek Cendikiawan Nusantara

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Pandemi COVID-19 telah menimbulkan tantangan global yang signifikan sejak munculnya virus SARS-CoV-2 pada tahun 2020. Pengendalian penyakit ini menjadi prioritas kesehatan utama mengingat dampaknya yang luas. Indonesia juga terpengaruh dengan laporan kasus pertama COVID-19 pada Maret 2020, membutuhkan perhatian serius dalam penanganannya. Salah satu komorbiditas yang sering terjadi pada pasien COVID-19 adalah penyakit ginjal kronis (CKD), yang meningkatkan risiko komplikasi medis. Pemahaman yang lebih mendalam tentang penggunaan obat antivirus pada pasien CKD yang terinfeksi COVID-19 menjadi penting, mengingat potensi toksisitas obat dan interaksi yang mungkin terjadi. Meskipun obat antivirus seperti favipiravir dan remdesivir telah menjadi strategi penting dalam penanganan COVID-19, perhatian khusus diperlukan saat memberikannya kepada pasien CKD karena risiko akumulasi dan toksisitas yang lebih tinggi. Studi potong lintang yang dilakukan di RSUD Dr. Soedomo Trenggalek bertujuan untuk mengevaluasi penggunaan obat antivirus pada pasien COVID-19 dengan CKD. Hasilnya menunjukkan bahwa mayoritas pasien menerima favipiravir (64%) dibandingkan dengan remdesivir (36%). Namun, penggunaannya perlu disesuaikan dengan fungsi ginjal pasien untuk menghindari toksisitas. Penelitian lebih lanjut diperlukan untuk memahami perbandingan efektivitas antara kedua jenis obat antivirus ini pada pasien CKD, sehingga dapat memberikan pedoman pengobatan yang lebih tepat bagi populasi pasien yang rentan ini
Gambaran Penggunaan Obat Tunggal Antihipertensi Pada Pasien Hipertensi Di Rawat Jalan Puskesmas Octavian Ashido Nababan; Fendy Prasetyawan; Yuneka Saristiana; Faisal Akhmal Muslihk; Ratna Mildawati; Isma Oktadiana
Jurnal Intelek Insan Cendikia Vol. 1 No. 1 (2024): Maret 2024
Publisher : PT. Intelek Cendikiawan Nusantara

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Hipertensi merupakan kondisi yang seringkali tidak menunjukkan gejala yang jelas dan dapat menjadi faktor risiko utama untuk berbagai penyakit kardiovaskular yang serius. Pengelolaan yang efektif dari hipertensi penting untuk mencegah komplikasi jangka panjang yang berpotensi fatal. Salah satu pendekatan utama dalam pengobatan hipertensi adalah penggunaan obat antihipertensi, baik dalam bentuk tunggal maupun kombinasi, tergantung pada kebutuhan setiap pasien. Di fasilitas kesehatan tingkat primer seperti Puskesmas, manajemen hipertensi sering dilakukan melalui pemberian obat tunggal sebagai terapi awal. Namun, penting untuk memahami pola penggunaan obat tunggal antihipertensi pada pasien hipertensi di rawat jalan Puskesmas. Penelitian ini bertujuan untuk memberikan gambaran yang jelas tentang bagaimana obat tunggal antihipertensi digunakan pada pasien hipertensi di Puskesmas. Metode penelitian ini adalah studi deskriptif yang mendalam dengan pendekatan retrospektif. Data pasien hipertensi dikumpulkan dari rekam medis pasien selama bulan September 2023. Hasil penelitian menunjukkan bahwa sebagian besar pasien hipertensi cenderung menggunakan kombinasi terapi daripada obat tunggal, dengan presentase penggunaan obat tunggal sebesar 35,82% dan penggunaan obat kombinasi sebesar 64,18%. Temuan ini menegaskan pentingnya strategi terapi kombinasi dalam manajemen hipertensi, yang didukung oleh efek aditif dan sinergis dari kombinasi obat serta kemampuan untuk mengurangi risiko efek samping. Dengan demikian, penelitian ini memberikan kontribusi penting bagi pengembangan pedoman pengobatan yang lebih efektif dan individualized bagi pasien hipertensi di tingkat fasilitas rawat jalan
Spesialisasi Profesi Apoteker Untuk Optimalisasi Pharmaceutical Care Dalam Pendidikan Apoteker Advanced Practice Fendy Prasetyawan; Yuneka Saristiana; Muhammad Nurul Fadel; Ema Jayanti Besan; Nanda Ardianto; Ilhawa Zahra
SEARCH: Science Education Research Journal Vol. 2 No. 2 (2024): April 2024
Publisher : IAIN Sorong

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47945/search.v2i2.1342

Abstract

Abstract Penelitian ini membahas pengembangan profesi apoteker di Indonesia menjadi Apoteker Spesialis dan Advanced Practice. Inisiatif ini dilaksanakan oleh Pengurus Pusat Ikatan Apoteker Indonesia (PP IAI), Kolegium Ilmu Farmasi Indonesia (KIFI), dan perguruan tinggi, dengan mengacu pada model pengembangan yang dirumuskan oleh International Pharmaceutical Federation (FIP). Proses ini mengadopsi dan mengadaptasi standar internasional untuk disesuaikan dengan kebutuhan dan kondisi lokal di Indonesia. Melalui pendekatan "adopt and adapt," mekanisme Rekognisi Pembelajaran Lampau (RPL) diintegrasikan dalam sistem registrasi online yang diperkenalkan oleh KIFI, mempermudah proses pendaftaran dan administrasi program pengembangan profesi. Penyesuaian kurikulum, metode pengajaran, dan sistem evaluasi dilakukan untuk menjamin relevansi dan kualitas pendidikan yang diberikan. Pengakuan internasional terhadap kompetensi apoteker Indonesia tidak hanya meningkatkan daya saing tenaga kerja tetapi juga membuka peluang kolaborasi internasional dan peningkatan kualitas layanan kesehatan. Inisiatif ini berdampak signifikan pada sistem kesehatan nasional dengan meningkatkan kompetensi apoteker dalam berbagai peminatan spesialis, termasuk farmasi nuklir, farmasi interna, farmasi neonatus dan anak, farmasi intensif, dan farmasi onkologi. KIFI bekerja sama dengan berbagai pihak untuk memastikan bahwa program pendidikan dan sertifikasi yang diselenggarakan memenuhi standar nasional dan internasional. Pengembangan ini menunjukkan komitmen Indonesia untuk meningkatkan kualitas pendidikan dan praktik farmasi, memastikan apoteker siap menghadapi tantangan kesehatan masa depan, dan memperkuat posisi Indonesia di kancah internasional. Dengan kolaborasi yang erat antara semua pemangku kepentingan, Indonesia dapat mencetak apoteker yang kompeten, profesional, dan siap berkontribusi pada peningkatan kualitas hidup masyarakat serta penguatan sistem kesehatan nasional.
Sosialisasi Penyakit Populer dikalangan muda-mudi melalui Penerapan Pola Hidup Sehat Ratna Mildawati; Ary Kristijono; Fendy Prasetyawan; Yuneka Saristiana; Bandhi Prasetya Nugroho
Jurnal Pengabdian Al-Amin Vol. 2 No. 1 (2024): January 2024
Publisher : STAI Al-Amin Gersik Kediri Lombok Barat-NTB

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.54723/jpa.v2i1.136

Abstract

Joint disease is a non-communicable disease that is often experienced by teenagers and middle-aged people. This disease is mostly suffered by the age group over 15 years which causes various complications. The aim of this program is to increase public knowledge, especially teenagers and middle-aged people, and understanding of gout and cholesterol, especially regarding how to prevent it, so that it can help improve the quality of public health. The method of this activity is carried out by means of online and offline education and socialization which is carried out in three stages. The first stage is preparation of activities, the second stage is implementation of activities, and the third stage is implementation of evaluation activities and preparation of reports. The implementation of this activity includes the stages of providing material, question and answer and ending with a posttest. The results after being given the material and the posttest showed an increase in knowledge and understanding about popular diseases according to the posttest score. It is hoped that this socialization will be able to prevent popular diseases that most young people experience, so that it can improve the quality of public health.
Strategi Pencegahan COVID-19: Peningkatan Imunitas Tubuh Melalui Edukasi Konsumsi Teh Kombucha Faisal Akhmal; Fendy Prasetyawan; Yuneka Saristiana; Ratna Mildawati; Anis Akhwan Dhafin
Jurnal Pengabdian Al-Amin Vol. 2 No. 1 (2024): January 2024
Publisher : STAI Al-Amin Gersik Kediri Lombok Barat-NTB

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.54723/jpa.v2i1.138

Abstract

The COVID-19 pandemic, triggered by the coronavirus 2 (SARS-CoV-2), demands a rapid and effective response to protect the global community. This article discusses prevention strategies with a focus on boosting the body's immunity through education and the consumption of kombucha tea. COVID-19 varies in symptoms and impacts, requiring a holistic approach. Kombucha tea, a result of fermenting sweet tea with a SCOBY, provides high nutrition and health benefits, particularly in strengthening the immune system. Community outreach activities are conducted to disseminate information to healthcare professionals and students, discussing the benefits of kombucha tea in enhancing immunity during the pandemic. The methods of these activities involve preparation, implementation of educational sessions, and participant satisfaction evaluations. Research findings highlight the potential of kombucha tea, especially its antioxidant and anti-inflammatory compounds, in enhancing the body's resilience against SARS-CoV-2. This strategy can be reinforced by emphasizing overall healthy lifestyles. Despite its promise, challenges in implementation require effective education and cross-sector collaboration. The conclusion emphasizes the importance of a holistic approach and education in building the foundation of public health amid the pandemic.
IDENTIFIKASI SENYAWA ANTIOKSIDAN EKSTRAK KULIT BUAH MANGGIS (Garcinia mangostana L.) : EKSTRAK KULIT BUAH MANGGIS Saristiana, Yuneka; Wahdi, Achmad; Prasetyawan, Fendy
WELL BEING Vol 9 No 1 (2024): Well Being
Publisher : LPPM STIKes Bahrul Ulum Jombang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51898/wb.v9i1.246

Abstract

This study aims to identify the antioxidant classes in mangosteen rind (Garcinia mangostana L.), which is known to be rich in natural antioxidants. Antioxidants are compounds that can prevent or slow down cell damage caused by free radicals, which can form through metabolism or environmental exposure. The identification and utilization of natural sources of antioxidants are crucial for protecting cells from damage and supporting health. The research process began with the drying and grinding of mangosteen rind into a fine powder, which was then extracted using ethanol to obtain an antioxidant-rich extract. Subsequently, several phytochemical tests were conducted to identify antioxidant classes such as flavonoids, phenolic compounds, and tannins in the extract. The antioxidant activity assay was performed using the DPPH method, an in vitro method to measure antioxidant activity based on the color change of the DPPH solution that reacts with antioxidant compounds. The extract of mangosteen rind contains alkaloid, flavonoid, saponin, tannin, and steroid compounds. Additionally, the extract of mangosteen rind has potential as an antioxidant with an IC50 value of 48.9685 µg/mL.
Co-Authors Abd Rofiq Abd Rofiq Abd Rofiq Abd Rofiq Achmad Wahdi Adiyansyah Lukman Hakim Adiyansyah Lukman Hakim Akhmal Muslikh, Faisal Alshol, Mohammad Firdaus Althaf Rajahala B Sinun Amanda, Cornelia Ana Amalia Anis Akhwan Dhafin Anis Akhwan Dhafin Anis Akwan Dhafin Anita Dwi Setyarini Anita Dwi Setyarini Arifani Siswidiasari Arikha Ayu Susilowati Arsiaty Sumule Ary Kristijono Ary Kristijono Asrizal Azis Astutik, Widhi Azis, Asrizal Baarik Lana Fadli Bandhi Prasetya Nugroho Bandhi Prasetya Nugroho Besan, Emma Jayanti Candra Arifin Chandra Arifin Chandra Arifin Chandra Arifin Chandra Arifin Charliandri Saputra Wahab Datin An Nisa Sukmawati Deo Rudita Febrian Waly Dewi Retno Puspitosari Dian Permatasari, Yunita Edda, Ilda Rambu Eka Hayati Rhomah Eka Nur Fatmawati Elfred Rinaldo Kasimo, Elfred Rinaldo Elsa Mahardika Putri Elsa Mahardika Putri Ema Jayanti Besan Ema Tri Wulan Emma Jayanti Besan Faisal Akhmal Faisal Akhmal Muslihk Faisal Akhmal Muslikh Faisal Akhmal Muslikh Faisal Akhmal Muslikh Febriana, Laela Fendy Prasetyawan Freitas, Maria Do Carmo Da Costa Hasriyani Hasriyani Hasriyani, Hasriyani Herman Ibrahim Fadlannul Haq Ibrahim Irsyadul Ibad Ibrahim Iskandar Alfaris Ilhawa Zahra Ilhawa Zahra Imran, Arlan K Indrayanti, Dian Isma Oktadiana Isma Oktadiana Juwita, Syntia Tanu Kadir, Mujtahid Bin Abd Kadir, Mujtahid Bin And Karingga, Devangga Darma Kholis, Muhammad Akbar Nur Laili , Nur Fahma Laili, Nur Fahma Leny Witaning Kusumati Lily Aina Lusiana Aprillia M. Wahyu Ariawan Marhenta, Yogi Bhakti Mebung, Konradus Klala Megasari, Elly Meri, Meri milda, ratna Mildawati, Ratna Mildwati, Ratna Muhammad Alviyan Shutiawan Muhammad Nurul Fadel Mujtahid Bin Abd Kadir Muslihk, Faisal Akhmal Nanda Ardianto Nanda Ardianto Nanda Ardianto Neni Probosiwi Nimas Ayu Rahardini Nina Nur Jannah Nisa Azzahra Dentika Novyananda Salmasfattah Novyananda Salmasfattah Nur Fahma Laili Octavian Ashido Nababan Octavian Ashido Nababan Okky Intan Mawarni Oktadiana, Isma Prayoga Fery Yuniarto Probosiwi , Neni Ratna Mildawati Ratna Mildawati Ratna Mildawati Ratna Mildawati Ratna Mildawati Ratna Mildawati Restyana, Anggi Rhomah, Eka Hayati Rika Wahyu Pujiastini Rochmad Krissanjaya Rofiq, Abd Rohmah, Eka Hayati Salmasfattah, Novyananda Salmasfattah, Novynanda savitri, Lisa Shinta Mayasari Shinta Mayasari Sugeng, Santoso Sukmawati , Datin An Nisa Susilo Margining Raharjo Tri Wulan, Ema Tsamrotul Ilmi Wahyu Ariawan Widhi Astutik Winartiana Wisnu Haryo Widyoko Wulan, Ema Tri Yanti, Novirma Yogi Bhakti Marhenta Yunita Dian Permatasari Yunita Dian Permatasari